- Sections
- C - Chimiemétallurgie
- C07K - Peptides
- C07K 14/33 - Peptides ayant plus de 20 amino-acidesGastrinesSomatostatinesMélanotropinesLeurs dérivés provenant de bactéries provenant de Clostridium (G)
Détention brevets de la classe C07K 14/33
Brevets de cette classe: 792
Historique des publications depuis 10 ans
|
58
|
51
|
61
|
70
|
69
|
71
|
58
|
49
|
45
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Allergan, Inc. | 2434 |
62 |
| MERZ PHARMA GmbH & CO. KGaA | 612 |
38 |
| Ipsen Biopharm Limited | 268 |
35 |
| President and Fellows of Harvard College | 5912 |
26 |
| Ipsen Bioinnovation Limited | 48 |
25 |
| Children's Medical Center Corporation | 1828 |
23 |
| Glaxosmithkline Biologicals S.A. | 1700 |
22 |
| Wisconsin Alumni Research Foundation | 3827 |
17 |
| The Regents of the University of California | 19544 |
15 |
| Pfizer Inc. | 3363 |
13 |
| Wyeth LLC | 669 |
13 |
| Daewoong Co., Ltd. | 63 |
11 |
| Revance Therapeutics, Inc. | 153 |
11 |
| Valneva Austria GmbH | 113 |
11 |
| Massachusetts Institute of Technology | 9921 |
10 |
| The Governors of the University of Alberta | 884 |
7 |
| University of Guelph | 349 |
7 |
| Vaxiion Therapeutics, LLC | 20 |
7 |
| New York University | 1687 |
6 |
| Osaka University | 3301 |
6 |
| Autres propriétaires | 427 |